Fa'amatalaga atili ― Samoan

Urticaria e masani ona alia'e mai ma'i ma'i ma'i su'e. O nisi taimi e fa'atasi ma le fula o le aano o lo'o i lalo. Togafitiga fa'amuamua e aofia ai le aloese mai fa'aoso, pe a iloa. O vaila'au ole laina muamua e aofia ai antihistamines fou, lea e mafai ona fetu'una'i i tui maualuga pe a mana'omia. O isi vaila'au e pei o antihistamines tuai, H2 blockers, leukotriene antagonists, antihistamines malolosi, ma vasega pupuu o corticosteroids e mafai ona fa'aopoopo e fai ma lagolago fa'aopoopo. I tulaga o lo'o fa'aauau pea le urticaria e ui lava i nei faiga, e mafai ona tu'uina atu gasegase i foma'i fa'apitoa mo togafitiga fa'aopoopo e pei ole omalizumab po'o le cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

O lenei iloiloga o loʻo faʻamatalaina ai taʻiala lata mai mo le togafitia o le urticaria ma ofoina atu malamalamaga fou i ona mafuaʻaga.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids